Business
Currency:USD
2022/FY
Stock NameRevenueRatio
Development, and potential commercialization of off-the-shelf viral immunotherapies125K100.00%
Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States125K100.00%